Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Weekly Wrap 11 February

Sophia Mavridis
February 11, 2022

Morning Bell 10 February

Paulina Peters
February 10, 2022

Morning Bell 9 February

Sophia Mavridis
February 9, 2022

Morning Bell 8 February

Paulina Peters
February 8, 2022

Morning Bell 7 February

Sophia Mavridis
February 7, 2022

Weekly Wrap 4 February

Sophia Mavridis
February 4, 2022

Morning Bell 3 February

Paulina Peters
February 3, 2022

Morning Bell February 2

Sophia Mavridis
February 2, 2022

Morning Bell 1 February

Paulina Peters
February 1, 2022

Morning Bell 31 January

Sophia Mavridis
January 31, 2022

Weekly Wrap 28 January

Sophia Mavridis
January 28, 2022